Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan

NCT02262663 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Clinical Trial, Phase I

Interventions

DRUG: Vilaprisan (BAY1002670)

Sponsor

Bayer